Pretreatment serum interleukin-12 levels in predicting sustained virological response among hepatitis C patients following Pegylated Interferon-α2β plus Ribavirin treatment.

Ann Gastroenterol · 2013 · PMC3959452 · PMID 24714408

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally non-significantno p-value reported

Using logistic regression analysis it was found that for an increase in IL-12 serum levels per 1 pg/mL, patients were more likely to respond by 163% (OR 2.63, 95%CI: 0.89-7.78, P=0.081), although the result was marginally non-significant.

also in 1,493 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.